Cencora, Inc.
NYSECOR is staging its sharpest recovery in months, up 5.6% on the week to $279.57, yet the stock is still nursing a steep year-to-date hole — and the most interesting tension right now is the gap between a genuinely bullish options picture and a Street that keeps cutting price targets even while holding positive ratings. The options market has swung hard toward the bullish end. The…
Snapshot as of 22 Jun 2026
COR is staging its sharpest recovery in months, up 5.6% on the week to $279.57, yet the stock is still nursing a steep year-to-date hole — and the most interesting tension right now is the gap between a genuinely…
Cencora heads into the back half of its fiscal year with a mixed Q2 print that crystallises the central debate around the stock: strong underlying earnings momentum versus top-line pressure that is now visible in…
Cencora reports second-quarter results on May 6 against a backdrop of retreating analyst targets, mild short-side pressure, and a valuation that has quietly compressed heading into the release. The most telling setup…
Cencora heads into its May 6 quarterly report with short sellers pulling back and the options market showing little urgency — a setup that looks more relaxed than charged. The most telling move in the data is what…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COR — free to start on ORTEX.
Sign up for free →Open COR on ORTEX